Daniel Holohan

Daniel Holohan is a PhD-trained immunologist and corporate strategist currently serving as the Director of Competitive & Strategic Insights in Immunology at AbbVie. Previously, Daniel held positions as the Senior Manager of Strategy at Tessera Therapeutics and Associate Director of Strategy at a gene therapy startup. With extensive consulting experience, Daniel has worked with clients ranging from start-ups to large pharmaceutical companies, specializing in rare diseases, new product development, and strategy design. Early in their career, Daniel engaged in significant research at institutions such as the University of Pittsburgh and UCSF, contributing to advancements in immunology and neuroscience.